Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy interactions and transition between services

Gazala Akram, Fiona Mitchell

Research output: Contribution to journalArticle

Abstract

Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.

LanguageEnglish
Article numbere228509
JournalBMJ Case Reports
Volume12
Issue number6
DOIs
Publication statusPublished - 14 Jun 2019

Fingerprint

Polypharmacy
Antipsychotic Agents
Adolescent Health Services
Child Psychiatry
Injections
Nursing Staff
Mental Health Services
Child Development
Cytochrome P-450 Enzyme System
Psychiatry
Health
Neurodevelopmental Disorders
Aripiprazole

Keywords

  • antipsychotics drugs
  • child psychiatry
  • polypharmacy

Cite this

@article{b3f879b01c9d452f96c733572bc78954,
title = "Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy interactions and transition between services",
abstract = "Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.",
keywords = "antipsychotics drugs, child psychiatry, polypharmacy",
author = "Gazala Akram and Fiona Mitchell",
year = "2019",
month = "6",
day = "14",
doi = "10.1136/bcr-2018-228509",
language = "English",
volume = "12",
journal = "BMJ Case Reports",
issn = "1757-790X",
number = "6",

}

TY - JOUR

T1 - Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy interactions and transition between services

AU - Akram, Gazala

AU - Mitchell, Fiona

PY - 2019/6/14

Y1 - 2019/6/14

N2 - Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.

AB - Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.

KW - antipsychotics drugs

KW - child psychiatry

KW - polypharmacy

U2 - 10.1136/bcr-2018-228509

DO - 10.1136/bcr-2018-228509

M3 - Article

VL - 12

JO - BMJ Case Reports

T2 - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

IS - 6

M1 - e228509

ER -